Meta-Analysis Comparing Reported Frequency of Atrial Fibrillation After Acute Coronary Syndromes in Asians Versus Whites

American Journal of Cardiology

Volumn 101, Issue 4, 2008, Pages 506-509

  Novaro, Gian M ^a   Asher, Craig R ^a   Bhatt, Deepak L ^b   Moliterno, David J ^c   Harrington, Robert A ^d   Lincoff, A Michael ^b   Newby, L Kristin ^d   Tcheng, James E ^d   Hsu, Amy P ^b   Pinski, Sergio L ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOPLASTY; ARTICLE; ASIAN; BODY MASS; CAUCASIAN; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; DIABETES MELLITUS; ETHNICITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION STRUCTURE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; ST SEGMENT ELEVATION; THROMBOCYTE AGGREGATION; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 38849127456     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.09.098     Document Type: Article

References (22)

1. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
2. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 335 (1996) 775-782
3. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 337 (1997) 1118-1123
4. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 357 (2001) 1905-1914
5. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 339 (1998) 436-443
6. IMPACT II Investigators. Randomized placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT II. Lancet 349 (1997) 1422-1428
7. The PARAGON Investigators. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. Circulation 97 (1998) 2386-2395
8. Sane D.C., Stump D.C., Topol E.J., Sigmon K.N., Clair W.K., Kereiakes D.J., George B.S., Stoddard M.F., Bates E.R., Stack R.S., and The Thrombolysis and Angioplasty in Myocardial Infarction Study Group. Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. Circulation 83 (1991) 170-175
9. Thomas L.C., Giles T.D., Stuckey W.J., Mautner R.K., and Iteld B.J. Racial differences in platelet survival time in patients with symptomatic coronary atherosclerosis. Arteriosclerosis 3 (1983) 138-140
10. Weir M.R., Gray J.M., Paster R., and Saunders E. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. Hypertension 26 (1995) 124-130
11. Lang C.C., Stein C.M., Brown R.M., Deegan R., Nelson R., He H.B., Wood M., and Wood A.J. Attenuation of isoproterenol-mediated vasodilation in blacks. N Engl J Med 333 (1995) 155-160
12. Taylor A.L., Ziesche S., Yancy C., Carson P., D'Agostino Jr. R., Ferdinand K., Taylor M., Adams K., Sabolinski M., Worcel M., Cohn J.N., and African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 (2004) 2049-2057
13. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., and Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 285 (2001) 2370-2375
14. Ruo B., Capra A.M., Jensvold N.G., and Go A.S. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes and Costs of Heart Failure (EPOCH) study. J Am Coll Cardiol 43 (2004) 429-435
15. Kelley G.P., Stellingworth M.A., Broyles S., and Glancy D.L. Electrocardiographic findings in 888 patients ≥90 years of age. Am J Cardiol 98 (2006) 1512-1514
16. Lip G.Y., Bawden L., Hodson R., Rutland E., Snatchfold J., and Beevers D.G. Atrial fibrillation amongst the Indo-Asian general practice population: the West Birmingham Atrial Fibrillation Project. Int J Cardiol 65 (1998) 187-192
17. Conway D.S., and Lip G.Y. Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project). Am J Cardiol 92 (2003) 1476-1479
18. Newton J.D., Blackledge H.M., and Squire I.B. Ethnicity and variation in prognosis for patients newly hospitalized for heart failure: a matched historical cohort study. Heart 91 (2005) 1545-1550
19. Tsai C.T., Lai L.P., Lin J.L., Chiang F.T., Hwang J.J., Ritchie M.D., Moore J.H., Hsu K.L., Tseng C.D., Liau C.S., and Tseng Y.Z. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109 (2004) 1640-1646
20. Wall J.D., and Pritchard J.K. Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 4 (2003) 587-597
21. Yang Y., Xia M., Jin Q., Bendahhou S., Shi J., Chen Y., Liang B., Lin J., Liu Y., Liu B., et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am Hum Genet 75 (2004) 899-905
22. Xia M., Jin Q., Bendahhou S., He Y., Larroque M.M., Chen Y., Zhou Q., Yang Y., Liu Y., Liu B., et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 332 (2005) 1012-1019